Archive for the ‘Health Care Stocks’ Category

« Older Entries
Newer Entries »

LZR merges, MSFT moving, CRME skips a beat

Monday, February 7th, 2011

Emergent Group Inc. (AMEX: LZR) shares sprang up 38.8 per cent to $8.41, on volume of 284,325 or more than 11 times its daily average. Monday, it was announced that LZR was to be acquired by Universal Hospital Services for $8.46 a share.

Microsoft Inc. (Nasdaq: MSFT) traded in 25.3 million shares, pursuing a daily average of 58.4 million. Share prices added 1.6 percent to $28.22, amid general momentum in the tech world.

Cardiome Pharma Corporation (Nasdaq: CRME) lost 11.4 percent Monday to $6.06. Volume was 561,971 shares, nearly twice its normal daily average. Vancouver-based CRME is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system.

Tags: , , , , , , , ,
Posted in Health Care Stocks, Technology Stocks | No Comments »

BEC gets bought, C sells, DEAR dives

Monday, February 7th, 2011

Beckman Coulter Inc. (NYSE: BEC) shares gained 9.7 percent to $82.49, on volume of nearly 27 million shares, towering over its average of 1.3 million, after industrial company Danaher Corp. (NYSE: DHR) said it would buy the medical-diagnostics firm in a deal valued at about $6.8 billion. Danaher shares traveled higher 3.5 percent to $49.68.

Citigroup Inc. (NYSE: C) was busy on the markets Monday, trading in 75 million shares, catching up on a daily average of 561 million. Share prices added 0.9 percent to $4.86. C announced that its Global Transaction Services has launched a new module within its TreasuryVision® portal that simplifies how companies manage internal lending relationships between their legal entities.

Dearborn Bancorp Inc. (Nasdaq: DEAR) lost 11 percent Monday to $1.54. Volume for the stock was 165,420 shares, leading its normal daily average of 116,091, after reporting Friday a quarterly loss of $2.4 million, still less than half its loss in the prior-year quarter.

Tags: , , , , , , , ,
Posted in Financial Stocks, Health Care Stocks | No Comments »

EL up, PFE active, FBN floored

Thursday, February 3rd, 2011

Estee Lauder Cos. (NYSE: EL) shares gained 14.8 percent to $92.49, on volume of 4.9 million – or quadruple its daily average, after the cosmetics maker raised its fiscal-year forecast.

Pfizer Inc. (NYSE: PFE) was busy on the markets Thursday, trading in 52.5 million shares, beating out its daily average of 47 million. Share prices marched again 1.4 percent to $19.22, although biotechs in general were flat to downward Thursday.

Furniture Brands International (NYSE: FBN) lost 17.7 percent of its price strength Thursday to $3.78. Volume for the stock was 4.9 million shares, or more than 12 times its normal daily average, after reporting Thursday a net Q4 loss of $44.7 million, still an improvement from the quarterly loss of $65 million it suffered a year earlier.

Tags: , , , , , , ,
Posted in Consumer Discretionary Stocks, Health Care Stocks | No Comments »

CELL rings, INTC trades widely, ICGN takes breather

Thursday, February 3rd, 2011

Brightpoint Inc. (Nasdaq: CELL) shares moved north 32 percent Thursday to $12.57, on volumes of nearly three million, six times its full-day average, a day after presenting Q4 earnings that beat Street estimates.

Intel Inc. (Nasdaq: INTC) traded in 27.3 million shares Thursday, trailing its all-day average of 55.5 million. Shares for the chipmaker nosed ahead 0.6 percent to $21.50.

Icagen Inc. (Nasdaq: ICGN) got thumped 12.6 percent in price to $3.25 Thursday. Volume was 809,218, besting its daily average of 563,036, after the FDA lifted its hold on ICGN’s epilepsy drug.

Tags: , , , , , , ,
Posted in Consumer Discretionary Stocks, Health Care Stocks, Technology Stocks | No Comments »

DSCI ascends, MSFT steady, TZOO mauled

Thursday, February 3rd, 2011

Derma Sciences Inc. (Nasdaq: DSCI) shares traveled 39.3 percent Thursday to $9.29 Thursday, on volumes of 494,316, compared to its full-day average of around 27,000, after learning its diabetic foot-wound drug met their mid-stage trial goal.

Microsoft Corporation (Nasdaq: MSFT) bought and sold 34.3 million Thursday, trailing its all-day average of 59.4 million. Share prices dipped back 1.1 percent to $27.63, after announcing MSFT may use a sale of debt products to reward shareholders.

Travelzoo Inc. (Nasdaq: TZOO) fell in price 15.6 percent to $44.52 Thursday. Volume was 1.3 million compared to a daily average of 281,000, after announcing quarterly EPS of 23 cents, compared to nine cents in the prior-year quarter.

Tags: , , , , , , ,
Posted in Health Care Stocks, Technology Stocks | No Comments »

« Older Entries
Newer Entries »